Probiotics and prebiotics in atopic dermatitis: Pros and cons (Review)
| Autor: | Laura Mihaela Ion, Daniela Hosseyni, Daniel Boda, Ionut Serban Fanfaret, Poliana Leru, Sabina Loredana Corcea, Selda Ali, Roxana Silvia Bumbăcea |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
medicine.medical_specialty Skin barrier atopic dermatitis Dose medicine.diagnostic_test chronic ski inflammation business.industry Synbiotics cons gut microbiome Review General Medicine Disease Atopic dermatitis medicine.disease Allergic sensitization probiotics Immunology and Microbiology (miscellaneous) Internal medicine medicine SCORAD synbiotics prebiotics business |
| Zdroj: | Experimental and Therapeutic Medicine |
| ISSN: | 1792-1015 1792-0981 |
| DOI: | 10.3892/etm.2021.10811 |
| Popis: | Atopic dermatitis (AD) represents a chronic inflammatory skin condition in which the skin barrier is impaired; thus, the permeability is increased. Hence, there is a greater risk of allergic sensitization, as well as a higher pH and lower protection against resident microbes. Since this condition is currently increasing among children, it requires further study, as little is known regarding the pathogenesis that makes the skin prone to chronic relapsing inflammation. Trying to standardize the data regarding the use of prebiotics and probiotics in AD, we encountered tremendous variability in the literature data. Literature abounds in conflicting data: studies regarding prophylactic and therapeutic applications, different types of strains and dosages, applications in young children up to 5 years of age and above, usage of probiotics alone, prebiotics alone or synbiotics combined. There are also conflicting data regarding the outcome of these studies; some confirming a positive effect of prebiotics, probiotics or synbiotics and some showing no efficacy at all. The articles were divided into those assessing probiotics or prebiotics alone and a combination of the two, with studies showing a positive effect and studies proving no efficacy at all. We tried to critically analyze those articles showing weak and strong points. In summary, the most studied probiotics were the strains of Lactobacilli and Bifidobacteria. The Severity Scoring of Atopic Dermatitis (SCORAD) index was used to measure the efficacy of the treatment. Most studies compared their results with a placebo group and the efficacy when seen in moderate to severe forms of AD in patients with other allergic diseases present. However, the results are difficult to interpret, as in many studies the authors suggest that the disease may have a tendency to improve in time in some groups of patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|